SIOG 2024: Updates in medical oncology
19 Feb 2025
SIOG 2024: Updates in medical oncology
Multiple Myeloma: evolving paradigm - Panel Discussion
Choosing Wisely in endometrial & cervix cancers: Medical therapy
ESMO 2024: Highlights and analysis
ESMO 2024: Latest in bladder cancer - expert review
FOLFOX with selective use of 5FUCRT is non-inferior to 5FUCRT for treatment of LARC prior to low anterior resection with TME
IORT at hospital Del Mar Barcelona in Spain
IORT at University Hospital Augsburg in Germany
NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy in locally advanced rectal cancer